Opposite potentiality of hypothalamic coexpressed neuropeptides, apelin and vasopressin in maintaining body-fluid homeostasis.

Opposite potentiality of hypothalamic coexpressed neuropeptides, apelin and vasopressin in maintaining body-fluid homeostasis. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Opposite potentiality of hypothalamic coexpressed neuropeptides, apelin and vasopressin in maintaining body-fluid homeostasis. Abstract Text:

This review concentrates on the characteristics and functionality of endocrine neurons in the hypothalamo-neurohypophysial system, coexpressing two peptides, vasopressin and apelin. Vasopressin is synthesized in the soma of magnocellular neurons, then packaged in granules with its respective receptors. In these neurons, apelin is generated from a larger precursor proapelin and is detected in vesicles, some of them colocalize with vasopressin, for others there is a marked segregation of apelin and vasopressin immunoreactivity along the hypothalamo-hypophyseal axons. Furthermore, apelin receptors, like V1a-type and V1b-type vasopressin receptors, are synthesized by magnocellular vasopressin neurons. In lactating rodents, apelin given intracerebroventricularly inhibited the phasic electrical activity of vasopressin neurons, reduced plasma vasopressin levels and increased aqueous diuresis, showing that apelin acts as a potent diuretic neuropeptide, counteracting vasopressin actions through inhibition of vasopressin neuron activity and vasopressin release. Moreover, in response to potent physiological stimuli known to evoke increased phasic activity of vasopressin neurons (hyper-osmolarity like during dehydration), both the soma dendrites and neurohypophysial terminals loose their dense staining quality, and vasopressin is released by (i) dendrites in the extracellular space to optimize the characteristic phasic activity necessary to a sustained release of vasopressin and (ii) by terminals in blood circulation where vasopressin then ensures its main endocrine actions at kidney level (antidiuretic effect). Conversely, apelin accumulates in these neurons rather than being released into the bloodstream and probably into the nuclei. Thus, decreases in the local supply of apelin to magnocellular vasopressin cell bodies may facilitate the expression by vasopressin neurons of an optimized phasic activity, by decreasing the inhibitory actions of apelin on these neurons. Antagonistic regulation of apelin and vasopressin has a biological purpose, making it possible to maintain the water balance of the organism by preventing additional water loss via kidneys. This reveals a new physiological concept of dual and opposite functional potentiality for endocrine neurons coexpressing different neuropeptides in separate vesicles: depending on the degree of their electrical activation/inhibition, neurons release selectively the very coexpressed peptides that will ensure its accurate endocrine functions in perfect accordance with the hormonal demand.

Opposite potentiality of hypothalamic coexpressed neuropeptides, apelin and vasopressin in maintaining body-fluid homeostasis. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Opposite potentiality of hypothalamic coexpressed neuropeptides, apelin and vasopressin in maintaining body-fluid homeostasis. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Progress in brain research

VOLUME: 170

Page Numbers: 559-70

Journal Abbreviation: Prog. Brain Res.

ISSN: 0079-6123

DAY: 28

MONTH: 07

YEAR: 2008

Opposite potentiality of hypothalamic coexpressed neuropeptides, apelin and vasopressin in maintaining body-fluid homeostasis. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 376441

Opposite potentiality of hypothalamic coexpressed neuropeptides, apelin and vasopressin in maintaining body-fluid homeostasis. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Opposite potentiality of hypothalamic coexpressed neuropeptides, apelin and vasopressin in maintaining body-fluid homeostasis. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Opposite potentiality of hypothalamic coexpressed neuropeptides, apelin and vasopressin in maintaining body-fluid homeostasis.

AFFILIATION: INSERM, U 691; Collège de France; Université Pierre et Marie Curie; 11 Place Marcelin Berthelot, Paris, France.

Country: Netherlands

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Prog Brain Res

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Opposite potentiality of hypothalamic coexpressed neuropeptides, apelin and vasopressin in maintaining body-fluid homeostasis Related Publications

• Active ingredients of substance use-focused self-help groups.
• Central anticholinergic syndrome: a case report.
• Conversation with Rudolf moos.
• Determinants of functioning and well-being among individuals with schizophrenia: an integrated model.
• Direct detection of formaldehyde in air by a novel NAD+- and glutathione-independent formaldehyde dehydrogenase-based biosensor.
• Effect of slow cathode rays on microorganisms.
• Emergent synchronous bursting of oxytocin neuronal network.
• Functioning status of adult children of depressed parents: a 23-year follow-up.
• Imaging performance of telescope mirrors for far-ultraviolet astronomy.
• Opposite potentiality of hypothalamic coexpressed neuropeptides, apelin and vasopressin in maintaining body-fluid homeostasis.
• Oxidative stress and damage in liver, but not in brain, of Fischer 344 rats subjected to dietary iron supplementation with lipid-soluble [(3,5,5-trimethylhexanoyl)ferrocene].
• Participation in specific treatment components predicts alcohol-specific and general coping skills.
• Personal and treatment-related predictors of abstinence self-efficacy.
• Predictors of 4-year outcome of community residential treatment for patients with substance use disorders.
• Predictors of changes in alcohol-related self-efficacy over 16 years.
• Predictors of outcome for patients with substance-use disorders five years after treatment dropout.
• Problem-free drinking over 16 years among individuals with alcohol use disorders.
• Protective resources and long-term recovery from alcohol use disorders.
• Screening psychiatric patients for illicit drug use disorders and problems.
• Solubilized human zona pellucida competes with a fucosylated neoglycoprotein for binding sites on the human sperm surface.
• Spatial imaging in the soft x-ray region (20-304 A) utilizing the astigmatism of a grazing incidence concave grating.
• Spirituality/religiosity promotes acceptance-based responding and 12-step involvement.
• Substance misuse among older adults: a neglected but treatable problem.
• Substance use disorder treatment programs in Switzerland and the USA: Program characteristics and 1-year outcomes.
• The basic aspects of radiation therapy.
• Treated and untreated alcohol-use disorders: course and predictors of remission and relapse.
• Upward pressures on drinking: exposure and reactivity in adulthood.
• Vg1 has specific processing requirements that restrict its action to body axis patterning centers.
• [Commentary] CONTEXT AND MECHANISMS OF REACTIVITY TO ASSESSMENT AND TREATMENT.
• [Not Available.]